![Sireesh Appajosyula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sireesh Appajosyula
Chief Executive Officer at
HEPION PHARMACEUTICALS, INC.
Net worth: 522 923 $ as of 2026-09-29
Profile
Dr. Sireesh Appajosyula is a Chief Executive Officer & Director at Hepion Pharmaceuticals, Inc., a Chief Executive Officer at Gravitas Life Sciences LLC, a Managing Member at Highpoint Pharmaceuticals LLC and a Managing Partner at Channel Bioconsulting LLC.
He is on the Board of Directors at Hepion Pharmaceuticals, Inc. Dr. Appajosyula was previously employed as a Chief Financial Officer by Tharimmune, Inc., a SVP-Corporate Development & Operations by 9 Meters Biopharma, Inc., and a Head-Business Development by Salix Pharmaceuticals, Inc. He received his undergraduate degree from Rutgers State University of New Jersey and a doctorate degree from Ernest Mario School of Pharmacy.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-30 | 3,250,000 ( 3.31% ) | 370 500 $ | 2026-09-29 | |
| 2026-06-15 | 64,178 ( 0.08% ) | 152 423 $ | 2026-09-29 |
Sireesh Appajosyula active positions
| Companies | Position | Start |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Chief Executive Officer | 2026-10-08 |
Highpoint Pharmaceuticals LLC | Corporate Officer/Principal | 2017-12-31 |
Channel Bioconsulting LLC | Corporate Officer/Principal | 2014-12-31 |
Former positions of Sireesh Appajosyula
| Companies | Position | End |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Chief Executive Officer | - |
| 9 METERS BIOPHARMA, INC. | Chief Operating Officer | 2023-07-16 |
Salix Pharmaceuticals, Inc.
 Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Education of Sireesh Appajosyula
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Tharimmune, Inc.
 Tharimmune, Inc. Data Processing ServicesTechnology Services Engages in institutional blockchain infrastructure and digital asset treasury management and clinical stage bio-technology services | Technology Services |
Highpoint Pharmaceuticals LLC | |
Channel Bioconsulting LLC |
- Stock Market
- Insiders
- Sireesh Appajosyula
